Is Johnson & Johnson ‘past its best’ in the current cycle?
With the recent $4.7 billion lawsuit against it, Johnson & Johnson has produced an upbeat earnings number for the second quarter (Q2). However Doctor Andy Smith, from Edison Investment Research, says the company may now have pipeline issues for the remainder of the year. Subscribe: https://www.youtube.com/IGUnitedKingdom?sub_confirmation=1 Learn more about IG: https://www.ig.com?CHID=9&SM=YT Twitter: https://twitter.com/IGcom Facebook: https://www.facebook.com/IGcom […]